Check-Cap Ltd. (CHEK)
NASDAQ: CHEK · Real-Time Price · USD
0.9073
-0.0627 (-6.46%)
At close: May 15, 2025, 4:00 PM
0.9699
+0.0626 (6.90%)
After-hours: May 15, 2025, 6:29 PM EDT
Check-Cap Market Cap
Check-Cap has a market cap or net worth of $5.31 million as of May 15, 2025. Its market cap has decreased by -59.16% in one year.
Market Cap
5.31M
Enterprise Value
-12.52M
1-Year Change
-59.16%
Ranking
Category
Stock Price
$0.91
Market Cap Chart
Since March 4, 2015, Check-Cap's market cap has decreased from $33.40M to $5.31M, a decrease of -84.11%. That is a compound annual growth rate of -16.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2025 | 5.70M | -1.72% |
| Dec 31, 2024 | 5.80M | -52.46% |
| Dec 29, 2023 | 12.20M | -4.69% |
| Dec 30, 2022 | 12.80M | -80.31% |
| Dec 31, 2021 | 65.00M | 205.16% |
| Dec 31, 2020 | 21.30M | 131.52% |
| Dec 31, 2019 | 9.20M | 162.86% |
| Dec 31, 2018 | 3.50M | -73.48% |
| Dec 29, 2017 | 13.20M | -52.52% |
| Dec 30, 2016 | 27.80M | 167.31% |
| Dec 31, 2015 | 10.40M | -68.86% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 658.30B |
| Johnson & Johnson | 359.97B |
| AbbVie | 320.92B |
| Novo Nordisk | 289.00B |
| UnitedHealth Group | 248.87B |
| Abbott Laboratories | 232.01B |
| Novartis AG | 211.47B |
| AstraZeneca | 208.86B |